The international guidelines for diagnosing multiple sclerosis (MS), called the McDonald criteria, underwent their most ...

A noninvasive brain stimulation technique may help adults with multiple sclerosis walk farther and improve their balance.

Certain gut bacteria may influence the odds of developing MS, in part by altering the activity of specific immune cells, ...

Multiple sclerosis is a chronic autoimmune disorder that affects the central nervous system, causing episodes of neurologic dysfunction and often gradual disease progression. The immune system ...

The CD40–CD40L costimulatory pathway regulates adaptive and innate immune responses and has been implicated in the pathogenesis of multiple sclerosis. Frexalimab is a second-generation anti-CD40L ...

Multiple sclerosis isn’t inherited, but having a family member with the disease can increase your chance of having the condition. While genetics influences your risk, environmental factors also play a ...

BARCELONA, Spain — Annual dosing of rituximab for relapsing-remitting multiple sclerosis (RRMS) was noninferior to the typical dosing schedule of once every 6 months, which could offer a more ...

Prof Nicholas Schwab and his colleagues found a biomarker which allows to tell in advance if therapy with glatirameracetate will be efficient in an individual MS patent. Treatment with interferon or ...

Multiple sclerosis (MS) is a condition that affects the central nervous system. It disrupts the flow of information between the brain and the rest of the body. In mild cases of MS, people can ...

Sanofi wins EU nod for Cenrifki in secondary progressive multiple sclerosis without relapses, while Wayrilz gets Japan nod for immune thrombocytopenia.